ABOUT THIS EVENT

ALX Oncology Holdings Inc. (Nasdaq: ALXO), is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system, rang the Nasdaq Opening Bell remotely from across the country.

In celebration of its IPO, Jaume Pons, Ph.D., President & Chief Executive Officer, rang the Opening Bell alongside the Company’s team in a virtual bell ringing ceremony.